Middle Meningeal Artery Embolization and the Treatment of a Chronic Subdural Hematoma

Likowsky L Désir1, Randy D'Amico1, Thomas Link1

  • 1Department of Neurological Surgery, Lenox Hill Hospital, New York City, USA.

Cureus
|November 10, 2021
PubMed

Insights

Middle meningeal artery (MMA) embolization offers a new treatment for chronic subdural hematoma (cSDH). This minimally invasive procedure may reduce recurrence after surgery by targeting the hematoma

Area of Science:

  • Neurosurgery
  • Interventional Radiology

Background:

  • Chronic subdural hematoma (cSDH) is a common condition, particularly in the elderly.
  • Current treatments include observation for asymptomatic cases and surgical evacuation for symptomatic ones, but recurrence rates can be high.

Purpose of the Study:

  • To review the existing literature on middle meningeal artery (MMA) embolization for cSDH.
  • To discuss the pathophysiology of cSDH and the mechanism of MMA embolization.

Main Methods:

  • Literature review of studies on MMA embolization for cSDH.
  • Discussion of the vascular supply to the subdural space and the role of the MMA.

Main Results:

  • MMA embolization is an emerging treatment option for cSDH.
  • The procedure aims to reduce inflammation and neovascularization within the hematoma capsule.

Conclusions:

  • MMA embolization presents a promising alternative or adjunct treatment for cSDH.
  • Further research is needed to establish its efficacy and optimal use in clinical practice.

Related Concept Videos